11.12.25 -- Scaling Smarter In Biologics Manufacturing

Oxygen heterogeneity, caused by pressure variations and other factors in large-scale bioreactors, significantly impacts cell growth and product yield, necessitating careful control and understanding of these scale-dependent effects to enable successful biopharmaceutical manufacturing and technology transfer.

Small-scale downstream studies play a critical role in enabling efficient, low-risk tech transfer by providing data-driven insights that ensure process robustness, support regulatory compliance, and accelerate the transition from development to commercial manufacturing.

In this webinar, experts showcase how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.